C. Vanrensburg

The antiproliferative riminophenazine agents clofazimine and b669 promote lysophospholipid-mediated inhibition of na+, k+-adenosine triphosphatase-activity in cancer cell-lines in-vitro.

R. Anderson, E. DeBruyn, C. Vanrensburg, 1994, International journal of oncology.

Evaluation of the antineoplastic activities of the riminophenazine agents clofazimine and b669 in tumor-bearing rats and mice.

C. Durandt, P. Garliński, C. Vanrensburg, 1993, International journal of oncology.